Phage therapy: Concept to cure

Frontiers in Microbiology

Volumn 3, Issue JUL, 2012, Pages

  Keen, Eric C ^a  

^a Montgomery College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870980350     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00238     Document Type: Article

References (34)

1. Abedon, S., Kuhl, S., Blasdel, B., and Kutter, E. (2011). Phage treatment of human infections. Bacteriophage 1, 66-85.
2. Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A., Powell, B., Carlton, R., and Merril, C. (2002). Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70, 204-210.
3. Bruttin, A., and Brussow, H. (2005). Human volunteers receiving Escherischia coli phage T4 orally: a safety test of phage therapy. Antimicrob. Agents Chemother. 49, 2874-2878.
4. Buffie, C., Jarchum, I., Equinda, M., Lipuma, L., Gobourne, A., Viale, A., Ubeda-Morant, C., Xavier, J., and Pamer, E. (2011). Profound alterations of intestinal microbiata following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect. Immun. 80, 62-73.
5. Bull, J., Levin, B., DeRouin, T., Walker, N., and Bloch, C. (2002). Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol. 2, 35. doi: 10.1186/1471-2180-2-35
6. Cairns, B., Timms, A., Jansen, V., Connerton, I., and Payne, R. (2009). Quantitative models of in vitro bacteriophage-host dynamics and their application to phage therapy. PLoS Pathog. 5, e1000253. doi: 10.1371/journal.ppat.1000253
7. Espy, M., Uhl, J., Sloan, L., Buckwalter, S., Jones, M., Vetter, E., Yao, J., Wengenack, N., Rosenblatt, J., Cockerill, F., and Smith, T. (2006). Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin. Microbiol. Rev. 19, 165-256.
8. Hawkins, C., Harper, D., Burch, D., Anggard, E., and Soothill, J. (2010). Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial. Vet. Microbiol. 146, 309-313.
9. Ho, K. (2001). Bacteriophage therapy for bacterial infections: rekindling a memory. Perspect. Biol. Med. 44, 1-16.
10. Hughes, J. (2011). Preserving the lifesaving power of antimicrobial agents. JAMA 305, 1027-1028.
11. Inal, J. (2003). Phage therapy: a reappraisal of bacteriophages as antibiotics. Arch. Immunol. Ther. Exp. 51, 237-244.
12. Kim, K., Cha, J., Jang, E., Klumpp, J., Hagens, S., Hardt, W., Lee, K., and Loessner, M. (2008). PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response. Microb. Biotechnol. 1, 247-257.
13. Kropinksi, A. (2006). Phage therapy - everything old is new again. Can. J. Infect. Dis. Med. Microbiol. 17, 297-306.
14. Kutateladze, M., and Adamia, R. (2010). Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 28, 591-595.
15. Larckum, N. (1932). Bacteriophage in clinical medicine. J. Lab. Clin. Med. 17, 675.
16. Lederberg, J. (1996). Smaller fleas...ad infinitum: therapeutic bacteriophage redux. Proc. Natl. Acad. Sci. U.S.A. 93, 3167-3168.
17. Liljeqvist, T., Andresen, D., Zuo, Y., and Weston, C. (2012). Antibiotic resistance: moving forward to the past. N.S.W. Public Health Bull. 23, 37.
18. Lu, T., and Koeris, M. (2011). The next generation of bacteriophage therapy. Curr. Opin. Microbiol. 14, 524-531.
19. Marwick, C. (2000). Merits, flaws of live flu vaccine debated. JAMA 283, 1814-1815.
20. Matsuzaki, S., Rashel, M., Uchiyama, J., Sakurai, S., Ujihara, T., Kuroda, M., Ikeuchi, M., Tani, T., Fujieda, M., Wakiguchi, H., and Imai, S. (2005). Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J. Infect. Chemother. 11, 211-219.
21. Merril, C., Biswas, B., Carlton, R., Jensen, N., Creed, G., Zullo, S., and Adhya, S. (1996). Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. U.S.A. 93, 3188-3192.
22. Merril, C., Scholl, D., and Adhya, S. (2003). The prospect for bacteriophage therapy in Western medicine. Nat. Rev. Drug Discov. 2, 489-497.
23. Mohaidat, Q., Sheikh, K., Palchaudhuri, S., and Rehse, S. (2012). Pathogen identification with laser-induced breakdown spectroscopy: the effect of bacterial and bio-fluid specimen contamination. Appl. Opt. 51, 99-107.
24. Nathan, C, and Goldberg, F. (2005). The profit problem in antibiotic R&D. Nat. Rev. Drug Discov. 4, 887-891.
25. O'Hara, A., and Shanahan, E (2006). The gut flora as a forgotten organ. EMBO Rep. 7, 688-693.
26. Rhoads, D., Wolcott, R., Kuskowski, M., Wolcott, B., Ward, L., and Sulakvelidze, A. (2009). Bacteriophage therapy of various leg ulcers in humans: results of a phase I safety trial. J. Wound Care 18, 237-243
27. Rhoads, D., Wolcott, R., Sun, Y., and Dowd, S. (2012). Comparison of culture and molecular identification of bacteria in chronic wounds. Int. J. Mol. Sci. 13, 2535-2550.
28. Slopek, S., Weber-Dabrowska, B., Dabrowski, M., and Kucharewicz-Krukowska, A. (1987). Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch. Immunol. Ther. Exp. 35, 569-583.
29. Sulakvelidze, A., Alavidze, Z., and Morris, J. (2001). Bacteriophage therapy. Antimicrob. Agents Chemother. 45, 649-659.
30. Thiel, K. (2004). Old dogma, new tricks - 21st century phage therapy. Nat. Biotechnol. 22, 31-36.
31. Williams Smith, H., Huggins, M., and Shaw, K. (1987). The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J. Gen. Microbiol. 133, 1111-1126.
32. Wright, A., Hawkins, C., Anggard, E., and Harper, D. (2009). A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin. Otolaryngol. 34, 349-357.
33. Yan, F., and Polk, B. (2004). Commensal bacteria in the gut: learning who our friends are. Curr. Opin. Gastroenterol. 20, 565-571.
34. Zhukov-Verezhnikov, N., Peremitina, L., Berillo, E., Komissarov, V., Bardymov, P., Khvoles, A., and Ugrymov, L. (1978). A study of the therapeutic effect of bacteriophage agents in a complex treatment of suppurative surgical diseases. Sov. Med. 23, 64-66.